FOI release

MHRA FOIA Request -Lasix 40mg tablets PAR

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2025/00098

Received 5 February 2025

Published 31 March 2025

Request

We would like to request a copy of the Public Assessment report (UK PAR) and information if its Initial application of the following product under the Freedom of Information Act (FOIA) of MHRA. This product has been discontinued in UK. We would like to know if the product Lasix 40mg Tablets was authorized through a DCP route where UK was included with the Procedure? We tried to search this but could not get any information about it in the public domain. Product name: Lasix 40mg Tablets Date of 1st Authorization: March 1965 MAH name: Aventis Pharma Limited 410 Thames Valley Park Drive Reading, Berkshire RG6 1PT, UK Trading as: Sanofi Genzyme 410 Thames Valley Park Drive Reading, Berkshire RG6 1PT, UK PL number: Not available

Response

see attached

Documents

• FOI2025_00098 redacted for publication.pdf (103.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.